Clinical trial NCT01364454: General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening
Official title: Effect of Eligible Patients Paper-based Reminder for General Practitioners on Colorectal Cancer Screening Participation
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: EARLY_PHASE1
Conditions: Colorectal Cancer
Keywords: Colorectal Cancer Screening
Faecal Occult Blood test
General Practitioners Involvement
Patient's Participation
Reminder
Lead sponsor: Paris 12 Val de Marne University
Sponsor class: OTHER
First posted: 2011-06-02
Enrollment: 8140
Sex: ALL
Minimum age (years): 50
Maximum age (years): 74
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SCREENING

Brief summary: Screening for ColoRectal Cancer (CRC) is widely recommended because of compelling evidence that it reduces mortality from CRC and that it's cost-effective. In France, there is a national CRC screening programme inviting people aged 50-74 years by mail to consult their General Practitioner (GP) for a free on charge Faecal Occult Blood test deliverance every two years. Participation is a key factor for the screening programs success. High levels of screening uptake and the continued participation to regular screening must be achieved and maintained in the targeted population if the enormous potential of CRC screening is to be realised. Screening rates of various international programs vary widely (20-52%) and the participation is insufficient in the most settings. Therefore, a better understanding of facilitating and hindering factors of patient participation can guide interventions to improve CRC screening rates. They include patients and physicians' factors. One issue is about GPs practice. GP involvement has been shown to improve the participation in the CRC screening. This study aims to assess the effectiveness of an intervention targeting GPs to increase patient participation in the CRC screening. Volunteer GPs will be randomly assigned to either the intervention group or to usual care (control group) and they will be followed one year. The intervention consists in providing every four months to the experimental group a list of their patients who are eligible but did not proceed yet to the screening. In both groups, patient participation in the screening will be measured at the end of the study.


Eligibility criteria: Inclusion Criteria:

1. General Practitioner (GP)

   * exercising in the Val de Marne (French department of the suburb of Paris)
   * volunteered to participate at the study
2. Patient

   * living in the Val de Marne (French department of the suburb of Paris)
   * having declared a 'preferred GP' exercising in the Val de Marne to the main statutory health insurance scheme ("régime général")
   * being eligible for colorectal cancer screening (aged 50 to 74 years, not excluded and having not proceed yet to the screening)
   * having consulted his 'preferred GP', whatever the reason, during the study period

Exclusion Criteria:

Primary outcomes:
measure: Patient's participation to colorectal cancer screening program
timeFrame: 1 year
Secondary outcomes:
Other outcomes:
Locations:
city: Créteil
country: France
facility: Département Universitaire d'Enseignement et de Recherche en Médecine Générale
Study officials:
affiliation: DUERMG
name: Julien Le Breton, MD, MPH
role: PRINCIPAL_INVESTIGATOR
References: